Assesment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease.

Trial Profile

Assesment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2013

At a glance

  • Drugs Mibampator (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 17 Feb 2011 Planned end date changed from 1 Oct 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top